NewsBenzingaFlex prevé un BPA ajustado del tercer trimestre de 1,19-1,25 dólares frente a una estimación de 1,22 dólares; prevé ventas de 8.870 millones-9.170 millones de dólares frente a una estimación de 8.953 millones de dólares Flex prevé un BPA ajustado del tercer trimestre de 1,19-1,25 dólares frente a una estimación de 1,22 dólares; prevé ventas de 8.870 millones-9.170 millones de dólares frente a una estimación de 8.953 millones de dólares Benzinga 2026.10.28 11:12 (GMT+0) Open on Benzinga Other news Global-E Online Stock Is Falling Wednesday: What's Going On? Grifols Presents New Real-World Evidence Data From AMBAR Program, Contributing To Ongoing Research Evaluating Use Of TPE With Albumin Replacement In Patients With Alzheimer’s Disease HC Wainwright & Co. Maintains Buy on LifeMD, Lowers Price Target to $6 Stifel Maintains Buy on Ecolab, Raises Price Target to $356 Stifel Upgrades Tandem Diabetes Care to Buy, Raises Price Target to $26 Immuneering Presents Preclinical Data Demonstrating Potential Of Atebimetinib; Phase 2 Results Include Long Survival And Outstanding Tolerability Profile In First-Line Pancreatic Cancer Patients
Grifols Presents New Real-World Evidence Data From AMBAR Program, Contributing To Ongoing Research Evaluating Use Of TPE With Albumin Replacement In Patients With Alzheimer’s Disease
Immuneering Presents Preclinical Data Demonstrating Potential Of Atebimetinib; Phase 2 Results Include Long Survival And Outstanding Tolerability Profile In First-Line Pancreatic Cancer Patients